4
Changes in Ownership
Invivyd, Inc. Filed Acc 0001193125-26-057828
Chief Scientific Officer sold 37,581 shares at an average $1.56 ($58,600)
- Chief Scientific Officer acquired 99,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Allen Robert D. III Chief Scientific Officer | 2026-02-15 | Option exercise 10b5-1 | +99,000 | 152,068 | D | ||
| Allen Robert D. III Chief Scientific Officer | 2026-02-17 | Sale 10b5-1 | −18,189 | $1.54 | $28,004 | 133,879 | D |
| Allen Robert D. III Chief Scientific Officer | 2026-02-18 | Sale 10b5-1 | −19,392 | $1.58 | $30,597 | 114,487 | D |
| Derivatives | |||||||
| Allen Robert D. III Chief Scientific Officer | 2026-02-15 | Option exercise · Restricted Stock Units 10b5-1 | −99,000 | 102,000 | D | ||
| Open-market sales · 37,581 sh · avg $1.56 · $58,600 | |||||||
Loading xslF345X05/ownership.xml…